Seth Klarman - Baupost Group

Holding/activity history for  Theravance Biopharma Inc. (TBPH)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 0 0 Sell 100.00% 1.01
2024   Q2 4,200,021 1.01 Reduce 36.31% 0.58 $8.48
2024   Q1 6,594,126 1.67 Reduce 11.12% 0.21 $8.97
2023   Q4 7,419,226 1.82 $11.24
2023   Q3 7,419,226 1.24 $8.63
2023   Q2 7,419,226 1.39 Reduce 28.79% 0.56 $10.35
2023   Q1 10,419,226 2.02 Reduce 8.76% 0.19 $10.85
2022   Q4 11,419,226 2.18 Reduce 14.90% 0.38 $11.22
2022   Q3 13,419,226 2.42 $10.14
2022   Q2 13,419,226 1.86 Reduce 1.64% 0.03 $9.06
2022   Q1 13,643,333 1.44 Reduce 0.12% 0.00 $9.56
2021   Q4 13,660,168 1.53 $11.05
2021   Q3 13,660,168 0.95 Add 37.84% 0.26 $7.40
2021   Q2 9,910,168 1.17 Add 13.45% 0.14 $14.52
2021   Q1 8,735,168 1.42 $20.41
2020   Q4 8,735,168 1.44 $17.77
2020   Q3 8,735,168 1.40 Reduce 6.17% 0.09 $14.78
2020   Q2 9,309,168 2.45 $20.99
2020   Q1 9,309,168 3.19 $23.11
2019   Q4 9,309,168 2.80 $25.89
2019   Q3 9,309,168 2.13 $19.48
2019   Q2 9,309,168 1.42 $16.33
2019   Q1 9,309,168 1.83 $22.67
2018   Q4 9,309,168 2.14 $25.59
2018   Q3 9,309,168 2.39 $32.67
2018   Q2 9,309,168 1.90 $22.68
2018   Q1 9,309,168 2.19 $24.25
2017   Q4 9,309,168 2.58 $27.89
2017   Q3 9,309,168 3.99 Add 0.38% 0.02 $34.24
2017   Q2 9,273,991 4.25 $39.84
2017   Q1 9,273,991 4.05 $36.82
2016   Q4 9,273,991 3.89 Add 26.16% 0.81 $31.88
2016   Q3 7,350,991 3.81 $36.24
2016   Q2 7,350,991 2.28 Add 13.07% 0.26 $22.69
2016   Q1 6,500,991 1.78 Add 1.26% 0.02 $18.80
2015   Q4 6,420,028 1.93 $16.39
2015   Q3 6,420,028 1.19 $10.99
2015   Q2 6,420,028 1.41 Add 0.84% 0.01 $13.02
2015   Q1 6,366,577 1.90 Add 5.04% 0.09 $17.35
2014   Q4 6,061,228 1.83 $14.92
2014   Q3 6,061,228 2.50 $23.05
2014   Q2 6,061,228 3.20 Buy 3.20 $31.88